Thursday, October 6, 2016

Gene Therapy - Table of Contents alert Volume 23 Issue 10

If you are unable to see the message below, click here to view.
Gene Therapy

Advertisement
Download the New AAV Lentivirus and Adenovirus Handbook 

Do you struggle with gene delivery in vitro or in vivo?

Consider AAV, lentivirus or adenovirus as vectors

Download free Virus Handbook to learn more.

TABLE OF CONTENTS

Volume 23, Issue 10 (October 2016)

In this issue
Commentary
Original Articles

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Take a look at our new Editor's Choice page

Gene Therapy is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers, and have been selected because readers will find them particularly interesting or useful.

View the Editor's Choice articles
 

Commentary

Top

Novel approaches toward managing the micromanagers: ‘non-toxic’ but effective

T G H Diekwisch

Gene Ther 2016 23: 697-698; advance online publication, July 7, 2016; 10.1038/gt.2016.49

Full Text

Original Articles

Top

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system OPEN

F DeRosa, B Guild, S Karve, L Smith, K Love, J R Dorkin, K J Kauffman, J Zhang, B Yahalom, D G Anderson and M W Heartlein

Gene Ther 2016 23: 699-707; advance online publication, June 30, 2016; 10.1038/gt.2016.46

Abstract | Full Text

Synthetic certified DNA reference material for analysis of human erythropoietin transgene and transcript in gene doping and gene therapy

A Baoutina, S Bhat, M Zheng, L Partis, M Dobeson, I E Alexander and K R Emslie

Gene Ther 2016 23: 708-717; advance online publication, June 7, 2016; 10.1038/gt.2016.47

Abstract | Full Text

A dual chain chimeric antigen receptor (CAR) in the native antibody format for targeting immune cells towards cancer cells without the need of an scFv

E Faitschuk, V Nagy, A A Hombach and H Abken

Gene Ther 2016 23: 718-726; advance online publication, June 14, 2016; 10.1038/gt.2016.48

Abstract | Full Text

siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases

X Ma, P Zhou, S W Wong, M Warner, C Chaulagain and R L Comenzo

Gene Ther 2016 23: 727-733; advance online publication, June 20, 2016; 10.1038/gt.2016.50

Abstract | Full Text

Identification of an alveolar type I epithelial cell-specific DNA nuclear import sequence for gene delivery

L Gottfried, X Lin, M Barravecchia and D A Dean

Gene Ther 2016 23: 734-742; advance online publication, July 1, 2016; 10.1038/gt.2016.52

Abstract | Full Text

Long-term, high-level hepatic secretion of acid α-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus

D P W Rastall, S S Seregin, Y A Aldhamen, L M Kaiser, C Mullins, A Liou, F Ing, C Pereria-Hicks, S Godbehere-Roosa, D Palmer, P Ng and A Amalfitano

Gene Ther 2016 23: 743-752; advance online publication, July 1, 2016; 10.1038/gt.2016.53

Abstract | Full Text

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

C S Rollier, E J Verschoor, B E Verstrepen, J A R Drexhage, G Paranhos-Baccala, P Liljeström, G Sutter, L Arribillaga, J J Lasarte, B Bartosch, F-L Cosset, G Inchauspe and J L Heeney

Gene Ther 2016 23: 753-759; advance online publication, July 14, 2016; 10.1038/gt.2016.55

Abstract | Full Text

DREADDs suppress seizure-like activity in a mouse model of pharmacoresistant epileptic brain tissue

N Avaliani, M Andersson, A H Runegaard, D Woldbye and M Kokaia

Gene Ther 2016 23: 760-766; advance online publication, July 14, 2016; 10.1038/gt.2016.56

Abstract | Full Text

Advertisement
Have you tried listening to the Genepod, the podcast from Genetics in Medicine?

Hear direct from the experts, wherever you are and on whatever device. Past topics have included:
  • Investigating the lower risk of solid tumors in Down Syndrome
  • New and Old Quandaries in Newborn Screening
  • Time and effort to practice medical genetics: an expanding challenge
Listen to the Genepod and expand your genetics knowledge for free
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: